NCT01448135View on ClinicalTrials.gov

Tolerance and Efficacy of a Predigested, High Protein, High Omega 3 Fat Enteral Feeding Formula Versus a Standard Formula In Multiple Intensive Care Unit Settings

NACompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

October 31, 2011

Primary Completion Date

November 30, 2014

Study Completion Date

November 30, 2014

Conditions
Critical IllnessEnteral Feeding
Interventions
OTHER

VITAL AF

Semi-elemental, high protein, and high omega-3 fish oil enteral formula

OTHER

Osmolite 1.2

High protein enteral formula

Trial Locations (1)

10032

NewYork-Presbyterian Hospital at Columbia University Medical Center, New York

All Listed Sponsors
collaborator

Abbott Nutrition

INDUSTRY

lead

Columbia University

OTHER

NCT01448135 - Tolerance and Efficacy of a Predigested, High Protein, High Omega 3 Fat Enteral Feeding Formula Versus a Standard Formula In Multiple Intensive Care Unit Settings | Biotech Hunter | Biotech Hunter